跳至主要内容
临床试验/NCT02691013
NCT02691013Unknown不适用

The Impact of Ramelteon on Sleep and Delirium in Patients Who Undergo Pulmonary Thromboendarterectomy (PTE) Surgery

University of California, San Diego0 个研究点目标入组 120 人开始时间: 2016年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
120
主要终点
Duration of Delirium

研究概览

简要总结

Sleep deprivation is known to affect brain function but is often ignored in the sickest patients including those in the intensive care unit after major surgery. In these patients, the levels of melatonin can also be altered. Melatonin is a hormone secreted in the brain that maintains the body's sleep-wake, or circadian, cycle. The investigators want to test whether improving sleep quality affects the risk of developing confusion (delirium) in patients having clot removed from their lung (open heart surgery). In order to improve sleep quality, the investigators will conduct a study of Ramelteon, a medication that mimics the activity of melatonin and measure its effects on levels of melatonin and monitor sleep.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH) who are admitted to UCSD for a planned PTE surgery.
  • Age > 18 years

排除标准

  • Pregnancy
  • Cirrhosis of any etiology
  • Current use of any atypical antipsychotic including Fluvoxamine (contra-indicated with Ramelteon)
  • Any contraindication to EEG/Sleep recording
  • Non-English speaking (who are unable to complete delirium questionnaires)

研究组 & 干预措施

Placebo

Placebo Comparator

Patients will receive a Placebo tablet every evening.

干预措施: Placebo (Drug)

Ramelteon

Active Comparator

Patients will receive Ramelteon 8mg every evening.

干预措施: Ramelteon (Drug)

结局指标

主要结局

Duration of Delirium

时间窗: Twice daily for up to 10 days

Measured twice daily during the ICU stay using the Confusions Assessment Method instrument.

Total Duration of Sleep

时间窗: Daily for up to 10 days

Participants wore an actigraphy device on their wrist for the duration of their ICU stay. This device continuously measures activity, and thus estimates sleep time.

次要结局

  • Number of Participants With Delirium(Twice daily for up to 10 days)
  • Measures of the Sound Levels in the Patient's Room(3 days)
  • Average Daily Critical Care Pain Observation Tool (CPOT)(10 days)
  • Length of Hospital Stay(Duration of hospital admission)
  • Length of ICU Stay(Duration of hospital admission)
  • Measures of Light Quality in the Patient's Room(3 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert L. Owens

Associate Professor, Pulmonary, Critical Care and Sleep Medicine

University of California, San Diego

相似试验